Mason Street Advisors’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q1
Sell
-2,969
Closed -$1.73M 162
2020
Q4
$1.73M Sell
2,969
-35
-1% -$20.4K 0.03% 706
2020
Q3
$1.55M Sell
3,004
-47
-2% -$24.2K 0.03% 642
2020
Q2
$1.38M Sell
3,051
-8,442
-73% -$3.81M 0.03% 678
2020
Q1
$4.03M Hold
11,493
0.09% 200
2019
Q4
$4.25M Buy
11,493
+221
+2% +$81.8K 0.08% 249
2019
Q3
$3.75M Buy
11,272
+594
+6% +$198K 0.08% 271
2019
Q2
$3.34M Sell
10,678
-30
-0.3% -$9.38K 0.07% 320
2019
Q1
$3.27M Buy
10,708
+160
+2% +$48.9K 0.07% 317
2018
Q4
$2.45M Buy
10,548
+258
+3% +$59.9K 0.06% 359
2018
Q3
$3.22M Sell
10,290
-98
-0.9% -$30.7K 0.07% 317
2018
Q2
$3M Buy
10,388
+235
+2% +$67.8K 0.07% 329
2018
Q1
$2.54M Buy
10,153
+194
+2% +$48.5K 0.06% 402
2017
Q4
$2.38M Sell
9,959
-24
-0.2% -$5.73K 0.05% 435
2017
Q3
$2.22M Sell
9,983
-186
-2% -$41.3K 0.05% 449
2017
Q2
$2.3M Buy
10,169
+347
+4% +$78.5K 0.06% 426
2017
Q1
$1.96M Buy
9,822
+134
+1% +$26.7K 0.05% 487
2016
Q4
$1.77M Buy
9,688
+131
+1% +$23.9K 0.05% 522
2016
Q3
$1.57M Buy
9,557
+39
+0.4% +$6.39K 0.04% 551
2016
Q2
$1.36M Buy
9,518
+443
+5% +$63.3K 0.04% 607
2016
Q1
$1.24M Buy
9,075
+366
+4% +$50.1K 0.04% 642
2015
Q4
$1.21M Buy
8,709
+206
+2% +$28.6K 0.04% 622
2015
Q3
$1.14M Buy
8,503
+119
+1% +$16K 0.04% 638
2015
Q2
$1.26M Buy
8,384
+62
+0.7% +$9.34K 0.04% 623
2015
Q1
$1.13M Sell
8,322
-14,614
-64% -$1.98M 0.03% 696
2014
Q4
$2.77M Sell
22,936
-1,111
-5% -$134K 0.02% 824
2014
Q3
$2.73M Buy
24,047
+209
+0.9% +$23.7K 0.02% 797
2014
Q2
$2.85M Buy
23,838
+1,637
+7% +$196K 0.02% 781
2014
Q1
$2.84M Buy
22,201
+896
+4% +$115K 0.02% 784
2013
Q4
$2.63M Buy
21,305
+13,345
+168% +$1.65M 0.02% 802
2013
Q3
$936K Buy
7,960
+20
+0.3% +$2.35K 0.01% 974
2013
Q2
$891K Buy
+7,940
New +$891K 0.01% 931